ALTERATION IN MOLECULAR-STRUCTURE OF CYTOSKELETON PROTEINS IN GRISEOFULVIN-TREATED MOUSE-LIVER - A PRESSURE TUNING INFRARED-SPECTROSCOPY STUDY

被引:33
作者
CADRIN, M [1 ]
FRENCH, SW [1 ]
WONG, PTT [1 ]
机构
[1] NATL RES COUNCIL CANADA,STEACIE INST MOLEC SCI,OTTAWA K1A 0R6,ONTARIO,CANADA
基金
英国医学研究理事会;
关键词
D O I
10.1016/0014-4800(91)90050-8
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Different liver diseases are associated with modifications in hepatocyte cytoskeletal organization and formation of Mallory bodies (MBs). Since the structure of a protein is critical for its function, we studied the changes in the molecular structure of the cytoskeletal protein in the liver from mice fed griseofulvin (GF), which is a good animal model for studying liver disease. Using pressure-tuning infrared spectroscopy we compared the infrared spectra of the cytoskeletal proteins from control liver and griseofulvin treated liver. The results show that the overall structure of the cytoskeletal protein was modified by the griseofulvin treatment. A relative increase in the amount of α-helices to β-sheets was observed in the liver cytoskeleton from the GF-treated mice. Moreover, the random coil and the turn segments were dramatically decreased compared to controls. Pressure-induced modifications including denaturation were irreversible in the control samples whereas they were reversible in the griseofulvin-treated samples. These changes reflect important fundamental modifications in the molecular structure of the cytoskeletal proteins in the griseofulvin-treated hepatocytes. We suggest that these changes are related to the modification of the organization of intermediate filaments and the formation of MBs that occur in the GF-treated liver. © 1991.
引用
收藏
页码:170 / 179
页数:10
相关论文
共 38 条
[11]  
DENK H, 1975, LAB INVEST, V32, P773
[12]  
Denk H, 1989, Hepatology, V10, P514, DOI 10.1002/hep.1840100419
[13]  
DENK H, 1984, LIVER, V4, P208
[14]  
FRENCH SW, 1983, ARCH PATHOL LAB MED, V107, P445
[15]  
FRENCH SW, 1987, IAP MONOGRAPH, V28, P95
[16]  
HAZAN R, 1986, LAB INVEST, V54, P543
[17]   CHANGES IN THE CYTOKERATIN INTERMEDIATE FILAMENT CYTOSKELETON ASSOCIATED WITH MALLORY BODY FORMATION IN MOUSE AND HUMAN-LIVER [J].
KATSUMA, Y ;
SWIERENGA, SHH ;
KHETTRY, U ;
MARCEAU, N ;
FRENCH, SW .
HEPATOLOGY, 1987, 7 (06) :1215-1223
[18]   CYTOKERATIN INTERMEDIATE FILAMENTS OF RAT HEPATOCYTES - DIFFERENT CYTOSKELETAL DOMAINS AND THEIR 3-DIMENSIONAL STRUCTURE [J].
KATSUMA, Y ;
MARCEAU, N ;
OHTA, M ;
FRENCH, SW .
HEPATOLOGY, 1988, 8 (03) :559-568
[19]   ROLE OF CYTOKERATIN INTERMEDIATE FILAMENTS IN TRANSHEPATIC TRANSPORT AND CANALICULAR SECRETION [J].
KAWAHARA, H ;
CADRIN, M ;
PERRY, G ;
AUTILIOGAMBETTI, L ;
SWIERENGA, SHH ;
METUZALS, J ;
MARCEAU, N ;
FRENCH, SW .
HEPATOLOGY, 1990, 11 (03) :435-448
[20]  
KIMOFF RJ, 1981, LAB INVEST, V45, P491